Global Health to meet investors on June 19, 2026
Global Health Limited will hold a group meeting with analysts and institutional investors on June 19, 2026, in Noida. The session is organized by Motilal Oswal Financial Services Ltd and will not involve sharing unpublished price sensitive information.

*this image is generated using AI for illustrative purposes only.
Global Health Limited has scheduled a meeting with analysts and institutional investors on June 19, 2026, to discuss business performance and strategy. The management will engage with Motilal Oswal Financial Services Ltd during this session, which will be conducted in person in Noida. No unpublished price sensitive information will be disclosed during the meeting, adhering to regulatory compliance standards.
Meeting Schedule
The interaction is organized as per Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule includes a group meeting, subject to change due to unforeseen circumstances involving the analysts, investors, or the company.
| Name | Date of Meeting | Type of Meeting | Place of Meeting | Mode of Meeting |
|---|---|---|---|---|
| Motilal Oswal Financial Services Ltd | June 19, 2026 | Group Meeting | Noida | In Person |
Regulatory Compliance
The intimation was submitted to the stock exchanges by Rahul Ranjan, Company Secretary & Compliance Officer of Global Health Limited. The filing explicitly states that the purpose of this meeting is investor interaction and does not involve the sharing of material non-public information. The company has requested the exchanges to take the schedule on record.
Historical Stock Returns for Global Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.46% | -0.67% | +5.24% | +5.37% | +8.50% | +214.23% |
What strategic initiatives is Global Health Limited likely to emphasize during the meeting to attract institutional investors?
How might the engagement with Motilal Oswal Financial Services influence analyst ratings or price targets for the company?
What are the expected key performance indicators or growth metrics management will highlight for the upcoming fiscal year?






























